Study to Assess Platelet Dysfunction With Verify Now Assay

In-vitro Characterization of Platelet Dysfunction in Common Hematological Disorders Using the Verify Now Assay

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01167218

Enrollment

Registered

2010-07-22

Start date

2009-12-31

Completion date

2012-02-29

Last updated

2019-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet Aggregation Defects

Keywords

verify now assay for hematological disorders

Brief summary

The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).

Detailed description

Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet functional abnormalities in patients with hematological disorders.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

\- Patients with common blood disorders such as immune thrombocytopenia purpura(ITP) myelodysplastic syndrome MDS)and myeloproliferative disorders (MPV)

Exclusion criteria

\- Patients with normal platelet counts

Design outcomes

Primary

Measure	Time frame	Description
platelet aggregation defects	one year	to assess platelet aggregation defects

Countries

United States

Outcome results